Suppr超能文献

顺式和反式调控机制通过选择性的基于酪氨酸的基序控制 AP2 介导的 B 细胞受体内吞作用。

Cis and trans regulatory mechanisms control AP2-mediated B cell receptor endocytosis via select tyrosine-based motifs.

机构信息

Center for Immunology and Microbial Disease, Albany Medical College, Albany, New York, United States of America.

出版信息

PLoS One. 2013;8(1):e54938. doi: 10.1371/journal.pone.0054938. Epub 2013 Jan 23.

Abstract

Following antigen recognition, B cell receptor (BCR)-mediated endocytosis is the first step of antigen processing and presentation to CD4+ T cells, a crucial component of the initiation and control of the humoral immune response. Despite this, the molecular mechanism of BCR internalization is poorly understood. Recently, studies of activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) have shown that mutations within the BCR subunit CD79b leads to increased BCR surface expression, suggesting that CD79b may control BCR internalization. Adaptor protein 2 (AP2) is the major mediator of receptor endocytosis via clathrin-coated pits. The BCR contains five putative AP2-binding YxxØ motifs, including four that are present within two immunoreceptor tyrosine-based activation motifs (ITAMs). Using a combination of in vitro and in situ approaches, we establish that the sole mediator of AP2-dependent BCR internalization is the membrane proximal ITAM YxxØ motif in CD79b, which is a major target of mutation in ABC DLBCL. In addition, we establish that BCR internalization can be regulated at a minimum of two different levels: regulation of YxxØ AP2 binding in cis by downstream ITAM-embedded DCSM and QTAT regulatory elements and regulation in trans by the partner cytoplasmic domain of the CD79 heterodimer. Beyond establishing the basic rules governing BCR internalization, these results illustrate an underappreciated role for ITAM residues in controlling clathrin-dependent endocytosis and highlight the complex mechanisms that control the activity of AP2 binding motifs in this receptor system.

摘要

抗原识别后,BCR(B 细胞受体)介导的内吞作用是抗原加工和呈递给 CD4+T 细胞的第一步,是体液免疫应答启动和控制的关键组成部分。尽管如此,BCR 内化的分子机制仍知之甚少。最近,对激活 B 细胞样弥漫大 B 细胞淋巴瘤(ABC DLBCL)的研究表明,BCR 亚基 CD79b 内的突变导致 BCR 表面表达增加,这表明 CD79b 可能控制 BCR 内化。衔接蛋白 2(AP2)是通过网格蛋白包被凹陷介导受体内化的主要介质。BCR 包含五个假定的 AP2 结合 YxxØ 基序,其中四个位于两个免疫受体酪氨酸激活基序(ITAMs)内。我们使用体外和原位方法相结合,确定 AP2 依赖性 BCR 内化的唯一介质是 CD79b 中膜近端 ITAM YxxØ 基序,该基序是 ABC DLBCL 中主要的突变靶点。此外,我们确定 BCR 内化可以在至少两个不同水平上进行调节:通过下游 ITAM 嵌入的 DCSM 和 QTAT 调节元件在顺式调节 YxxØ AP2 结合,以及通过 CD79 异二聚体的伙伴胞质域在反式调节。除了确定控制 BCR 内化的基本规则外,这些结果还说明了 ITAM 残基在控制网格蛋白依赖性内吞作用中的作用被低估,并强调了控制该受体系统中 AP2 结合基序活性的复杂机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7a0/3553015/5e4d3a7af9c5/pone.0054938.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验